Gulersen Moti, Berghella Vincenzo, Bornstein Eran
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Lenox Hill Hospital-Zucker School of Medicine at Hofstra/Northwell, New York, NY 11549, USA.
J Clin Med. 2025 Aug 6;14(15):5544. doi: 10.3390/jcm14155544.
Singleton pregnancies complicated by a short cervical length (≤25 mm) are at significantly increased risk for spontaneous preterm birth. Several treatment strategies aimed at reducing this risk and improving perinatal outcomes have been evaluated, including vaginal progesterone, cervical cerclage, and cervical pessary. This review summarizes the latest evidence regarding the efficacy of these interventions. Vaginal progesterone and/or cervical cerclage have been identified as proven evidence-based practices for preterm birth prevention and improve neonatal outcomes. Vaginal progesterone reduces the risk of preterm birth < 35 weeks by 27% (relative risk 0.73, 95% confidence interval 0.58-0.90). Cervical cerclage has been shown to reduce the risk of preterm birth < 35 weeks by 30% (relative risk 0.70, 95% confidence interval 0.55-0.89) in patients with a short cervical length and prior preterm birth. In contrast, recent data suggest that cervical pessary should no longer be considered a management option for these patients. A continued focus on individualized, evidence-based approaches remains essential to optimizing outcomes in this high-risk population.
单胎妊娠合并宫颈短(≤25毫米)者自然早产风险显著增加。已评估了几种旨在降低此风险并改善围产期结局的治疗策略,包括阴道用黄体酮、宫颈环扎术和宫颈托。本综述总结了有关这些干预措施疗效的最新证据。阴道用黄体酮和/或宫颈环扎术已被确定为预防早产和改善新生儿结局的循证实践。阴道用黄体酮可使35周前早产风险降低27%(相对风险0.73,95%置信区间0.58 - 0.90)。对于宫颈短且有早产史的患者,宫颈环扎术已显示可使35周前早产风险降低30%(相对风险0.70,95%置信区间0.55 - 0.89)。相比之下,近期数据表明,宫颈托不应再被视为这些患者的一种治疗选择。持续关注个体化的循证方法对于优化这一高危人群的结局仍然至关重要。